nodes	percent_of_prediction	percent_of_DWPC	metapath
Gatifloxacin—ALB—Irinotecan—colon cancer	0.281	0.402	CbGbCtD
Gatifloxacin—ALB—Fluorouracil—colon cancer	0.27	0.386	CbGbCtD
Gatifloxacin—ALB—Methotrexate—colon cancer	0.149	0.213	CbGbCtD
Gatifloxacin—Sparfloxacin—ABCB1—colon cancer	0.00119	0.42	CrCbGaD
Gatifloxacin—Hallucination—Vincristine—colon cancer	0.000917	0.00309	CcSEcCtD
Gatifloxacin—Bradycardia—Irinotecan—colon cancer	0.000914	0.00308	CcSEcCtD
Gatifloxacin—Renal impairment—Capecitabine—colon cancer	0.000912	0.00307	CcSEcCtD
Gatifloxacin—Thirst—Capecitabine—colon cancer	0.000912	0.00307	CcSEcCtD
Gatifloxacin—Dermatitis bullous—Capecitabine—colon cancer	0.000909	0.00306	CcSEcCtD
Gatifloxacin—Epistaxis—Fluorouracil—colon cancer	0.000903	0.00304	CcSEcCtD
Gatifloxacin—Arthritis—Capecitabine—colon cancer	0.000894	0.00301	CcSEcCtD
Gatifloxacin—Vaginal inflammation—Methotrexate—colon cancer	0.000891	0.003	CcSEcCtD
Gatifloxacin—Gastrointestinal haemorrhage—Capecitabine—colon cancer	0.000868	0.00292	CcSEcCtD
Gatifloxacin—Visual impairment—Irinotecan—colon cancer	0.000865	0.00291	CcSEcCtD
Gatifloxacin—Migraine—Capecitabine—colon cancer	0.000855	0.00288	CcSEcCtD
Gatifloxacin—Pharyngitis—Fluorouracil—colon cancer	0.000853	0.00287	CcSEcCtD
Gatifloxacin—Vaginal infection—Methotrexate—colon cancer	0.000841	0.00283	CcSEcCtD
Gatifloxacin—Face oedema—Capecitabine—colon cancer	0.000838	0.00282	CcSEcCtD
Gatifloxacin—Levofloxacin—ABCB1—colon cancer	0.000838	0.295	CrCbGaD
Gatifloxacin—Ataxia—Capecitabine—colon cancer	0.000817	0.00275	CcSEcCtD
Gatifloxacin—Ciprofloxacin—ABCB1—colon cancer	0.000809	0.285	CrCbGaD
Gatifloxacin—Chills—Irinotecan—colon cancer	0.000805	0.00271	CcSEcCtD
Gatifloxacin—Mouth ulceration—Methotrexate—colon cancer	0.000805	0.00271	CcSEcCtD
Gatifloxacin—Ecchymosis—Methotrexate—colon cancer	0.000805	0.00271	CcSEcCtD
Gatifloxacin—Dry skin—Capecitabine—colon cancer	0.000796	0.00268	CcSEcCtD
Gatifloxacin—Nasopharyngitis—Capecitabine—colon cancer	0.000777	0.00261	CcSEcCtD
Gatifloxacin—Back pain—Vincristine—colon cancer	0.000776	0.00261	CcSEcCtD
Gatifloxacin—Flatulence—Irinotecan—colon cancer	0.00077	0.00259	CcSEcCtD
Gatifloxacin—Gastritis—Capecitabine—colon cancer	0.000769	0.00259	CcSEcCtD
Gatifloxacin—Muscular weakness—Capecitabine—colon cancer	0.000766	0.00258	CcSEcCtD
Gatifloxacin—Alanine aminotransferase increased—Capecitabine—colon cancer	0.000766	0.00258	CcSEcCtD
Gatifloxacin—Lymphadenopathy—Methotrexate—colon cancer	0.000758	0.00255	CcSEcCtD
Gatifloxacin—Back pain—Irinotecan—colon cancer	0.000756	0.00255	CcSEcCtD
Gatifloxacin—Muscle spasms—Irinotecan—colon cancer	0.000751	0.00253	CcSEcCtD
Gatifloxacin—Asthma—Capecitabine—colon cancer	0.000751	0.00253	CcSEcCtD
Gatifloxacin—Dysphagia—Capecitabine—colon cancer	0.000751	0.00253	CcSEcCtD
Gatifloxacin—Erythema—Fluorouracil—colon cancer	0.000748	0.00252	CcSEcCtD
Gatifloxacin—Diabetes mellitus—Methotrexate—colon cancer	0.000743	0.0025	CcSEcCtD
Gatifloxacin—Bronchospasm—Capecitabine—colon cancer	0.000738	0.00249	CcSEcCtD
Gatifloxacin—Agitation—Vincristine—colon cancer	0.000737	0.00248	CcSEcCtD
Gatifloxacin—Photosensitivity—Methotrexate—colon cancer	0.000736	0.00248	CcSEcCtD
Gatifloxacin—Vertigo—Vincristine—colon cancer	0.000721	0.00243	CcSEcCtD
Gatifloxacin—Vision blurred—Fluorouracil—colon cancer	0.000705	0.00238	CcSEcCtD
Gatifloxacin—Vertigo—Irinotecan—colon cancer	0.000702	0.00236	CcSEcCtD
Gatifloxacin—Dysuria—Capecitabine—colon cancer	0.000702	0.00236	CcSEcCtD
Gatifloxacin—Neutropenia—Capecitabine—colon cancer	0.000702	0.00236	CcSEcCtD
Gatifloxacin—Syncope—Irinotecan—colon cancer	0.000701	0.00236	CcSEcCtD
Gatifloxacin—Renal failure acute—Methotrexate—colon cancer	0.0007	0.00236	CcSEcCtD
Gatifloxacin—Convulsion—Vincristine—colon cancer	0.000695	0.00234	CcSEcCtD
Gatifloxacin—Hypertension—Vincristine—colon cancer	0.000693	0.00233	CcSEcCtD
Gatifloxacin—Loss of consciousness—Irinotecan—colon cancer	0.000687	0.00231	CcSEcCtD
Gatifloxacin—Photosensitivity reaction—Capecitabine—colon cancer	0.000685	0.00231	CcSEcCtD
Gatifloxacin—Myalgia—Vincristine—colon cancer	0.000683	0.0023	CcSEcCtD
Gatifloxacin—Hyperglycaemia—Capecitabine—colon cancer	0.000677	0.00228	CcSEcCtD
Gatifloxacin—Hypertension—Irinotecan—colon cancer	0.000675	0.00227	CcSEcCtD
Gatifloxacin—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.000663	0.00223	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Vincristine—colon cancer	0.000655	0.00221	CcSEcCtD
Gatifloxacin—Oedema—Vincristine—colon cancer	0.000655	0.00221	CcSEcCtD
Gatifloxacin—Stomatitis—Capecitabine—colon cancer	0.000652	0.0022	CcSEcCtD
Gatifloxacin—Infection—Vincristine—colon cancer	0.000651	0.00219	CcSEcCtD
Gatifloxacin—Conjunctivitis—Capecitabine—colon cancer	0.000651	0.00219	CcSEcCtD
Gatifloxacin—Convulsion—Fluorouracil—colon cancer	0.000648	0.00218	CcSEcCtD
Gatifloxacin—Confusional state—Irinotecan—colon cancer	0.000643	0.00217	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Vincristine—colon cancer	0.000641	0.00216	CcSEcCtD
Gatifloxacin—Haematuria—Capecitabine—colon cancer	0.000638	0.00215	CcSEcCtD
Gatifloxacin—Oedema—Irinotecan—colon cancer	0.000638	0.00215	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Irinotecan—colon cancer	0.000638	0.00215	CcSEcCtD
Gatifloxacin—Myalgia—Fluorouracil—colon cancer	0.000637	0.00215	CcSEcCtD
Gatifloxacin—Chest pain—Fluorouracil—colon cancer	0.000637	0.00215	CcSEcCtD
Gatifloxacin—Infection—Irinotecan—colon cancer	0.000634	0.00213	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Vincristine—colon cancer	0.000633	0.00213	CcSEcCtD
Gatifloxacin—Epistaxis—Capecitabine—colon cancer	0.000631	0.00213	CcSEcCtD
Gatifloxacin—Shock—Irinotecan—colon cancer	0.000627	0.00211	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Irinotecan—colon cancer	0.000624	0.0021	CcSEcCtD
Gatifloxacin—Anorexia—Vincristine—colon cancer	0.000624	0.0021	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Irinotecan—colon cancer	0.000617	0.00208	CcSEcCtD
Gatifloxacin—Confusional state—Fluorouracil—colon cancer	0.000616	0.00207	CcSEcCtD
Gatifloxacin—Hypotension—Vincristine—colon cancer	0.000612	0.00206	CcSEcCtD
Gatifloxacin—Bradycardia—Capecitabine—colon cancer	0.000612	0.00206	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Fluorouracil—colon cancer	0.000611	0.00206	CcSEcCtD
Gatifloxacin—Oedema—Fluorouracil—colon cancer	0.000611	0.00206	CcSEcCtD
Gatifloxacin—Anorexia—Irinotecan—colon cancer	0.000608	0.00205	CcSEcCtD
Gatifloxacin—Ataxia—Methotrexate—colon cancer	0.000608	0.00205	CcSEcCtD
Gatifloxacin—Infection—Fluorouracil—colon cancer	0.000607	0.00204	CcSEcCtD
Gatifloxacin—Hepatitis—Capecitabine—colon cancer	0.000601	0.00202	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Fluorouracil—colon cancer	0.000598	0.00201	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Vincristine—colon cancer	0.000597	0.00201	CcSEcCtD
Gatifloxacin—Pharyngitis—Capecitabine—colon cancer	0.000596	0.00201	CcSEcCtD
Gatifloxacin—Tachycardia—Fluorouracil—colon cancer	0.000596	0.00201	CcSEcCtD
Gatifloxacin—Hypotension—Irinotecan—colon cancer	0.000596	0.00201	CcSEcCtD
Gatifloxacin—Insomnia—Vincristine—colon cancer	0.000592	0.00199	CcSEcCtD
Gatifloxacin—Oedema peripheral—Capecitabine—colon cancer	0.000592	0.00199	CcSEcCtD
Gatifloxacin—Paraesthesia—Vincristine—colon cancer	0.000588	0.00198	CcSEcCtD
Gatifloxacin—Anorexia—Fluorouracil—colon cancer	0.000582	0.00196	CcSEcCtD
Gatifloxacin—Visual impairment—Capecitabine—colon cancer	0.000579	0.00195	CcSEcCtD
Gatifloxacin—Insomnia—Irinotecan—colon cancer	0.000577	0.00194	CcSEcCtD
Gatifloxacin—Paraesthesia—Irinotecan—colon cancer	0.000573	0.00193	CcSEcCtD
Gatifloxacin—Hypotension—Fluorouracil—colon cancer	0.000571	0.00192	CcSEcCtD
Gatifloxacin—Decreased appetite—Vincristine—colon cancer	0.000569	0.00192	CcSEcCtD
Gatifloxacin—Dyspnoea—Irinotecan—colon cancer	0.000569	0.00191	CcSEcCtD
Gatifloxacin—Erythema multiforme—Capecitabine—colon cancer	0.000568	0.00191	CcSEcCtD
Gatifloxacin—Somnolence—Irinotecan—colon cancer	0.000567	0.00191	CcSEcCtD
Gatifloxacin—Eye disorder—Capecitabine—colon cancer	0.000561	0.00189	CcSEcCtD
Gatifloxacin—Dyspepsia—Irinotecan—colon cancer	0.000561	0.00189	CcSEcCtD
Gatifloxacin—Tinnitus—Capecitabine—colon cancer	0.00056	0.00189	CcSEcCtD
Gatifloxacin—Constipation—Vincristine—colon cancer	0.00056	0.00189	CcSEcCtD
Gatifloxacin—Asthma—Methotrexate—colon cancer	0.000559	0.00188	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000556	0.00187	CcSEcCtD
Gatifloxacin—Decreased appetite—Irinotecan—colon cancer	0.000554	0.00187	CcSEcCtD
Gatifloxacin—Insomnia—Fluorouracil—colon cancer	0.000552	0.00186	CcSEcCtD
Gatifloxacin—Paraesthesia—Fluorouracil—colon cancer	0.000548	0.00185	CcSEcCtD
Gatifloxacin—Pancreatitis—Methotrexate—colon cancer	0.000548	0.00184	CcSEcCtD
Gatifloxacin—Constipation—Irinotecan—colon cancer	0.000545	0.00184	CcSEcCtD
Gatifloxacin—Dyspnoea—Fluorouracil—colon cancer	0.000545	0.00183	CcSEcCtD
Gatifloxacin—Somnolence—Fluorouracil—colon cancer	0.000543	0.00183	CcSEcCtD
Gatifloxacin—Chills—Capecitabine—colon cancer	0.000539	0.00182	CcSEcCtD
Gatifloxacin—Dyspepsia—Fluorouracil—colon cancer	0.000538	0.00181	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Vincristine—colon cancer	0.000535	0.0018	CcSEcCtD
Gatifloxacin—Decreased appetite—Fluorouracil—colon cancer	0.000531	0.00179	CcSEcCtD
Gatifloxacin—Feeling abnormal—Irinotecan—colon cancer	0.000526	0.00177	CcSEcCtD
Gatifloxacin—Erythema—Capecitabine—colon cancer	0.000523	0.00176	CcSEcCtD
Gatifloxacin—Neutropenia—Methotrexate—colon cancer	0.000522	0.00176	CcSEcCtD
Gatifloxacin—Dysuria—Methotrexate—colon cancer	0.000522	0.00176	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Irinotecan—colon cancer	0.000521	0.00176	CcSEcCtD
Gatifloxacin—Abdominal pain—Vincristine—colon cancer	0.000518	0.00174	CcSEcCtD
Gatifloxacin—Body temperature increased—Vincristine—colon cancer	0.000518	0.00174	CcSEcCtD
Gatifloxacin—Flatulence—Capecitabine—colon cancer	0.000515	0.00174	CcSEcCtD
Gatifloxacin—Dysgeusia—Capecitabine—colon cancer	0.000512	0.00172	CcSEcCtD
Gatifloxacin—Photosensitivity reaction—Methotrexate—colon cancer	0.00051	0.00172	CcSEcCtD
Gatifloxacin—Back pain—Capecitabine—colon cancer	0.000506	0.0017	CcSEcCtD
Gatifloxacin—Abdominal pain—Irinotecan—colon cancer	0.000504	0.0017	CcSEcCtD
Gatifloxacin—Body temperature increased—Irinotecan—colon cancer	0.000504	0.0017	CcSEcCtD
Gatifloxacin—Feeling abnormal—Fluorouracil—colon cancer	0.000503	0.00169	CcSEcCtD
Gatifloxacin—Muscle spasms—Capecitabine—colon cancer	0.000503	0.00169	CcSEcCtD
Gatifloxacin—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000494	0.00166	CcSEcCtD
Gatifloxacin—Vision blurred—Capecitabine—colon cancer	0.000493	0.00166	CcSEcCtD
Gatifloxacin—Tremor—Capecitabine—colon cancer	0.00049	0.00165	CcSEcCtD
Gatifloxacin—Stomatitis—Methotrexate—colon cancer	0.000486	0.00164	CcSEcCtD
Gatifloxacin—Urticaria—Fluorouracil—colon cancer	0.000485	0.00163	CcSEcCtD
Gatifloxacin—Conjunctivitis—Methotrexate—colon cancer	0.000484	0.00163	CcSEcCtD
Gatifloxacin—Body temperature increased—Fluorouracil—colon cancer	0.000483	0.00163	CcSEcCtD
Gatifloxacin—Hypersensitivity—Vincristine—colon cancer	0.000482	0.00162	CcSEcCtD
Gatifloxacin—Sweating—Methotrexate—colon cancer	0.000478	0.00161	CcSEcCtD
Gatifloxacin—Haematuria—Methotrexate—colon cancer	0.000475	0.0016	CcSEcCtD
Gatifloxacin—Epistaxis—Methotrexate—colon cancer	0.00047	0.00158	CcSEcCtD
Gatifloxacin—Vertigo—Capecitabine—colon cancer	0.00047	0.00158	CcSEcCtD
Gatifloxacin—Hypersensitivity—Irinotecan—colon cancer	0.00047	0.00158	CcSEcCtD
Gatifloxacin—Asthenia—Vincristine—colon cancer	0.00047	0.00158	CcSEcCtD
Gatifloxacin—Syncope—Capecitabine—colon cancer	0.000469	0.00158	CcSEcCtD
Gatifloxacin—Palpitations—Capecitabine—colon cancer	0.000462	0.00156	CcSEcCtD
Gatifloxacin—Loss of consciousness—Capecitabine—colon cancer	0.00046	0.00155	CcSEcCtD
Gatifloxacin—Asthenia—Irinotecan—colon cancer	0.000458	0.00154	CcSEcCtD
Gatifloxacin—Hypertension—Capecitabine—colon cancer	0.000452	0.00152	CcSEcCtD
Gatifloxacin—Hypersensitivity—Fluorouracil—colon cancer	0.00045	0.00152	CcSEcCtD
Gatifloxacin—Diarrhoea—Vincristine—colon cancer	0.000448	0.00151	CcSEcCtD
Gatifloxacin—Hepatitis—Methotrexate—colon cancer	0.000447	0.00151	CcSEcCtD
Gatifloxacin—Myalgia—Capecitabine—colon cancer	0.000445	0.0015	CcSEcCtD
Gatifloxacin—Arthralgia—Capecitabine—colon cancer	0.000445	0.0015	CcSEcCtD
Gatifloxacin—Chest pain—Capecitabine—colon cancer	0.000445	0.0015	CcSEcCtD
Gatifloxacin—Pharyngitis—Methotrexate—colon cancer	0.000444	0.00149	CcSEcCtD
Gatifloxacin—Anxiety—Capecitabine—colon cancer	0.000444	0.00149	CcSEcCtD
Gatifloxacin—Diarrhoea—Irinotecan—colon cancer	0.000436	0.00147	CcSEcCtD
Gatifloxacin—Dizziness—Vincristine—colon cancer	0.000433	0.00146	CcSEcCtD
Gatifloxacin—Pruritus—Fluorouracil—colon cancer	0.000432	0.00146	CcSEcCtD
Gatifloxacin—Visual impairment—Methotrexate—colon cancer	0.000431	0.00145	CcSEcCtD
Gatifloxacin—Confusional state—Capecitabine—colon cancer	0.00043	0.00145	CcSEcCtD
Gatifloxacin—Oedema—Capecitabine—colon cancer	0.000427	0.00144	CcSEcCtD
Gatifloxacin—Infection—Capecitabine—colon cancer	0.000424	0.00143	CcSEcCtD
Gatifloxacin—Erythema multiforme—Methotrexate—colon cancer	0.000423	0.00142	CcSEcCtD
Gatifloxacin—Dizziness—Irinotecan—colon cancer	0.000422	0.00142	CcSEcCtD
Gatifloxacin—Shock—Capecitabine—colon cancer	0.00042	0.00141	CcSEcCtD
Gatifloxacin—Eye disorder—Methotrexate—colon cancer	0.000418	0.00141	CcSEcCtD
Gatifloxacin—Diarrhoea—Fluorouracil—colon cancer	0.000418	0.00141	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Capecitabine—colon cancer	0.000418	0.00141	CcSEcCtD
Gatifloxacin—Tinnitus—Methotrexate—colon cancer	0.000417	0.0014	CcSEcCtD
Gatifloxacin—Tachycardia—Capecitabine—colon cancer	0.000417	0.0014	CcSEcCtD
Gatifloxacin—Vomiting—Vincristine—colon cancer	0.000416	0.0014	CcSEcCtD
Gatifloxacin—Rash—Vincristine—colon cancer	0.000413	0.00139	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Capecitabine—colon cancer	0.000413	0.00139	CcSEcCtD
Gatifloxacin—Dermatitis—Vincristine—colon cancer	0.000413	0.00139	CcSEcCtD
Gatifloxacin—Headache—Vincristine—colon cancer	0.00041	0.00138	CcSEcCtD
Gatifloxacin—Anorexia—Capecitabine—colon cancer	0.000407	0.00137	CcSEcCtD
Gatifloxacin—Vomiting—Irinotecan—colon cancer	0.000405	0.00137	CcSEcCtD
Gatifloxacin—Dizziness—Fluorouracil—colon cancer	0.000404	0.00136	CcSEcCtD
Gatifloxacin—Rash—Irinotecan—colon cancer	0.000402	0.00135	CcSEcCtD
Gatifloxacin—Dermatitis—Irinotecan—colon cancer	0.000402	0.00135	CcSEcCtD
Gatifloxacin—Chills—Methotrexate—colon cancer	0.000401	0.00135	CcSEcCtD
Gatifloxacin—Headache—Irinotecan—colon cancer	0.0004	0.00135	CcSEcCtD
Gatifloxacin—Hypotension—Capecitabine—colon cancer	0.000399	0.00134	CcSEcCtD
Gatifloxacin—Erythema—Methotrexate—colon cancer	0.000389	0.00131	CcSEcCtD
Gatifloxacin—Nausea—Vincristine—colon cancer	0.000389	0.00131	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000389	0.00131	CcSEcCtD
Gatifloxacin—Vomiting—Fluorouracil—colon cancer	0.000388	0.00131	CcSEcCtD
Gatifloxacin—Insomnia—Capecitabine—colon cancer	0.000386	0.0013	CcSEcCtD
Gatifloxacin—Rash—Fluorouracil—colon cancer	0.000385	0.0013	CcSEcCtD
Gatifloxacin—Dermatitis—Fluorouracil—colon cancer	0.000385	0.0013	CcSEcCtD
Gatifloxacin—Paraesthesia—Capecitabine—colon cancer	0.000383	0.00129	CcSEcCtD
Gatifloxacin—Headache—Fluorouracil—colon cancer	0.000383	0.00129	CcSEcCtD
Gatifloxacin—Dysgeusia—Methotrexate—colon cancer	0.000381	0.00128	CcSEcCtD
Gatifloxacin—Dyspnoea—Capecitabine—colon cancer	0.000381	0.00128	CcSEcCtD
Gatifloxacin—Nausea—Irinotecan—colon cancer	0.000379	0.00128	CcSEcCtD
Gatifloxacin—Back pain—Methotrexate—colon cancer	0.000377	0.00127	CcSEcCtD
Gatifloxacin—Dyspepsia—Capecitabine—colon cancer	0.000376	0.00127	CcSEcCtD
Gatifloxacin—Decreased appetite—Capecitabine—colon cancer	0.000371	0.00125	CcSEcCtD
Gatifloxacin—Vision blurred—Methotrexate—colon cancer	0.000367	0.00124	CcSEcCtD
Gatifloxacin—Constipation—Capecitabine—colon cancer	0.000365	0.00123	CcSEcCtD
Gatifloxacin—Nausea—Fluorouracil—colon cancer	0.000363	0.00122	CcSEcCtD
Gatifloxacin—Feeling abnormal—Capecitabine—colon cancer	0.000352	0.00118	CcSEcCtD
Gatifloxacin—Vertigo—Methotrexate—colon cancer	0.00035	0.00118	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Capecitabine—colon cancer	0.000349	0.00118	CcSEcCtD
Gatifloxacin—Urticaria—Capecitabine—colon cancer	0.000339	0.00114	CcSEcCtD
Gatifloxacin—Body temperature increased—Capecitabine—colon cancer	0.000337	0.00114	CcSEcCtD
Gatifloxacin—Abdominal pain—Capecitabine—colon cancer	0.000337	0.00114	CcSEcCtD
Gatifloxacin—Convulsion—Methotrexate—colon cancer	0.000337	0.00114	CcSEcCtD
Gatifloxacin—Chest pain—Methotrexate—colon cancer	0.000331	0.00112	CcSEcCtD
Gatifloxacin—Arthralgia—Methotrexate—colon cancer	0.000331	0.00112	CcSEcCtD
Gatifloxacin—Myalgia—Methotrexate—colon cancer	0.000331	0.00112	CcSEcCtD
Gatifloxacin—Confusional state—Methotrexate—colon cancer	0.00032	0.00108	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Methotrexate—colon cancer	0.000318	0.00107	CcSEcCtD
Gatifloxacin—Infection—Methotrexate—colon cancer	0.000316	0.00106	CcSEcCtD
Gatifloxacin—Hypersensitivity—Capecitabine—colon cancer	0.000314	0.00106	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Methotrexate—colon cancer	0.000311	0.00105	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Methotrexate—colon cancer	0.000307	0.00103	CcSEcCtD
Gatifloxacin—Asthenia—Capecitabine—colon cancer	0.000306	0.00103	CcSEcCtD
Gatifloxacin—Anorexia—Methotrexate—colon cancer	0.000303	0.00102	CcSEcCtD
Gatifloxacin—Pruritus—Capecitabine—colon cancer	0.000302	0.00102	CcSEcCtD
Gatifloxacin—Hypotension—Methotrexate—colon cancer	0.000297	0.001	CcSEcCtD
Gatifloxacin—Diarrhoea—Capecitabine—colon cancer	0.000292	0.000983	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000289	0.000975	CcSEcCtD
Gatifloxacin—Insomnia—Methotrexate—colon cancer	0.000287	0.000968	CcSEcCtD
Gatifloxacin—Paraesthesia—Methotrexate—colon cancer	0.000285	0.000961	CcSEcCtD
Gatifloxacin—Dyspnoea—Methotrexate—colon cancer	0.000283	0.000954	CcSEcCtD
Gatifloxacin—Somnolence—Methotrexate—colon cancer	0.000282	0.000951	CcSEcCtD
Gatifloxacin—Dizziness—Capecitabine—colon cancer	0.000282	0.00095	CcSEcCtD
Gatifloxacin—Dyspepsia—Methotrexate—colon cancer	0.00028	0.000942	CcSEcCtD
Gatifloxacin—Decreased appetite—Methotrexate—colon cancer	0.000276	0.00093	CcSEcCtD
Gatifloxacin—Vomiting—Capecitabine—colon cancer	0.000271	0.000914	CcSEcCtD
Gatifloxacin—Rash—Capecitabine—colon cancer	0.000269	0.000906	CcSEcCtD
Gatifloxacin—Dermatitis—Capecitabine—colon cancer	0.000269	0.000905	CcSEcCtD
Gatifloxacin—Headache—Capecitabine—colon cancer	0.000267	0.0009	CcSEcCtD
Gatifloxacin—Feeling abnormal—Methotrexate—colon cancer	0.000262	0.000882	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Methotrexate—colon cancer	0.00026	0.000875	CcSEcCtD
Gatifloxacin—Nausea—Capecitabine—colon cancer	0.000254	0.000854	CcSEcCtD
Gatifloxacin—Urticaria—Methotrexate—colon cancer	0.000252	0.00085	CcSEcCtD
Gatifloxacin—Abdominal pain—Methotrexate—colon cancer	0.000251	0.000846	CcSEcCtD
Gatifloxacin—Body temperature increased—Methotrexate—colon cancer	0.000251	0.000846	CcSEcCtD
Gatifloxacin—Hypersensitivity—Methotrexate—colon cancer	0.000234	0.000788	CcSEcCtD
Gatifloxacin—Asthenia—Methotrexate—colon cancer	0.000228	0.000768	CcSEcCtD
Gatifloxacin—Pruritus—Methotrexate—colon cancer	0.000225	0.000757	CcSEcCtD
Gatifloxacin—Diarrhoea—Methotrexate—colon cancer	0.000217	0.000732	CcSEcCtD
Gatifloxacin—Dizziness—Methotrexate—colon cancer	0.00021	0.000708	CcSEcCtD
Gatifloxacin—Vomiting—Methotrexate—colon cancer	0.000202	0.00068	CcSEcCtD
Gatifloxacin—Rash—Methotrexate—colon cancer	0.0002	0.000675	CcSEcCtD
Gatifloxacin—Dermatitis—Methotrexate—colon cancer	0.0002	0.000674	CcSEcCtD
Gatifloxacin—Headache—Methotrexate—colon cancer	0.000199	0.00067	CcSEcCtD
Gatifloxacin—Nausea—Methotrexate—colon cancer	0.000189	0.000636	CcSEcCtD
